孟德尔随机化在特发性肺纤维化中的应用现状及中医药探讨OA
Application Status of Mendelian Randomization in Idiopathic Pulmonary Fibrosis and a Discussion on Traditional Chinese Medicine
特发性肺纤维化(IPF)是一种进行性、致死性和不可逆的间质性肺病,其病因尚不明确.近年来,孟德尔随机化(MR)分析在循证医学领域兴起,因其能够排除观察性研究和随机对照试验(RCTs)中的混杂因素和反向因果影响,成为广受欢迎的因果推断方法.本研究从个人因素、临床疾病和微观因子3个方面系统回顾MR在IPF中的应用现状,基于当前研究成果探讨"肺虚络瘀"理论框架下IPF发病机制及运用益气养阴活血通络法论治IPF的微观作用机理,提出当前MR在IPF应用进展中的机遇挑战,以期发现中医药循证医学新领域,并为IPF基础研究、临床研究及新药开发提供更多参考.
Idiopathic pulmonary fibrosis(IPF)is a progressive,fatal,and irreversible interstitial lung disease with an unknown etiology.In recent years,Mendelian randomization(MR)analysis has emerged as a popular method for causal inference in evidence-based medicine,as it minimizes confounding factors and reverse causality often present in observational studies and randomized controlled trials(RCTs).This article systematically reviews the current applications of MR in IPF from three perspectives:individual factors,clinical diseases,and molecular factors.Based on existing research,it further explores the pathogenesis of IPF within the theoretical framework of"lung deficiency and collateral stasis"and investigates the potential mechanisms by which the therapeutic approach of"tonifying qi,nourishing yin,activating blood circulation,and unblocking collaterals"may act on IPF at a molecular level.Finally,the opportunities and challenges in the current application of MR in IPF research are discussed,with the aim of identifying new avenues for evidence-based research in traditional Chinese medicine and providing insights for basic research,clinical studies,and drug development in IPF.
祝宏江;吕晓东;高晨曦;邹吉宇;庞立健;王梅;臧凝子;赵仲雪;刘勇明;杨丽
辽宁中医药大学 沈阳 110847辽宁中医药大学 沈阳 110847辽宁中医药大学 沈阳 110847辽宁中医药大学 沈阳 110847辽宁中医药大学附属医院 沈阳 110032辽宁中医药大学 沈阳 110847辽宁中医药大学附属医院 沈阳 110032辽宁中医药大学附属医院 沈阳 110032辽宁中医药大学附属医院 沈阳 110032辽宁中医药大学附属医院 沈阳 110032
医药卫生
特发性肺纤维化孟德尔随机化因果推断中医药循证研究风险因素
Idiopathic pulmonary fibrosisMendelian randomizationCausal inferenceEvidence-based research in TCMRisk factors
《世界科学技术-中医药现代化》 2026 (8)
2506-2522,17
国家自然科学基金委员会区域创新发展联合基金(U24A20777):肺络病理论及通络治法在特发性肺纤维化中的应用基础研究,负责人:吕晓东国家中医药管理局项目(国中医药人教函[2025]256号):第六批全国中医临床优秀人才研修项目,培养对象:杨丽辽宁省教育厅基本科研储备项目(2024-JYTCB-059):基于全转录组学ceRNA调控网络探讨IPF全程病机链中医微观辨证研究,负责人:杨丽.
评论